Tempus AI, Inc (TEM)
NASDAQ: TEM · Real-Time Price · USD
54.02
-4.13 (-7.10%)
Nov 21, 2024, 11:46 AM EST - Market open
Tempus AI Employees
Tempus AI had 1,952 employees as of December 31, 2022. The number of employees increased by 385 or 24.57% compared to the previous year.
Employees
1,952
Change (1Y)
385
Growth (1Y)
24.57%
Revenue / Employee
$328,095
Profits / Employee
-$410,198
Market Cap
8.51B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2022 | 1,952 | 385 | 24.57% |
| Dec 31, 2021 | 1,567 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| The Ensign Group | 35,300 |
| Chemed | 15,087 |
| Bruker | 9,707 |
| Bio-Rad Laboratories | 8,030 |
| Bio-Rad Laboratories | 8,030 |
| Masimo | 3,800 |
| HealthEquity | 3,150 |
| Roivant Sciences | 908 |
TEM News
- 8 days ago - Tempus AI: Pioneering The Future Of Precision Medicine Through AI-Driven Innovation - Seeking Alpha
- 9 days ago - Tempus Molecular Profiling Integration Now Available Through Flatiron's OncoEMR® - Business Wire
- 10 days ago - Tempus Publishes Study Highlighting Benefits of Concurrent RNA and DNA Sequencing in Advanced Cancer Care - Business Wire
- 12 days ago - Tempus AI, Inc. (TEM) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 13 days ago - Tempus Announces Nine Abstracts Accepted for Presentation at the 2024 Society for Immunotherapy of Cancer Annual Meeting - Business Wire
- 13 days ago - Tempus Announces the Clinical Launch of its Immune Profile Score Algorithmic Test - Business Wire
- 16 days ago - Tempus Reports Third Quarter 2024 Results and Agreement to Acquire Ambry Genetics - Business Wire
- 17 days ago - Tempus to Report Third Quarter 2024 Financial Results on November 4 - Business Wire